Cargando…

Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance

PURPOSE: Cardiac comorbidity is one of the leading causes of death among acromegaly patients. We aimed to investigate the reversibility of acromegalic cardiac involvement after surgical treatment using the gold standard method, cardiovascular magnetic resonance, and to explore the effects of endocri...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaopeng, Cao, Yihan, Cao, Jian, Li, Xiao, Liu, Peijun, Wang, Zihao, Gao, Lu, Bao, Xinjie, Xing, Bing, Wang, Yining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609918/
https://www.ncbi.nlm.nih.gov/pubmed/33193111
http://dx.doi.org/10.3389/fendo.2020.598948
_version_ 1783605096141029376
author Guo, Xiaopeng
Cao, Yihan
Cao, Jian
Li, Xiao
Liu, Peijun
Wang, Zihao
Gao, Lu
Bao, Xinjie
Xing, Bing
Wang, Yining
author_facet Guo, Xiaopeng
Cao, Yihan
Cao, Jian
Li, Xiao
Liu, Peijun
Wang, Zihao
Gao, Lu
Bao, Xinjie
Xing, Bing
Wang, Yining
author_sort Guo, Xiaopeng
collection PubMed
description PURPOSE: Cardiac comorbidity is one of the leading causes of death among acromegaly patients. We aimed to investigate the reversibility of acromegalic cardiac involvement after surgical treatment using the gold standard method, cardiovascular magnetic resonance, and to explore the effects of endocrine remission and gender on reversibility. METHODS: In this single-center, prospective cohort study, fifty untreated acromegaly patients were enrolled. Comprehensive cardiac assessments were performed using a 3.0 T magnetic resonance scanner before and 3 and 12 months after transsphenoidal adenomectomy. RESULTS: Preoperatively, left ventricular (LV) enlargement (13.0%), LV systolic dysfunction (6.5%), right ventricular (RV) enlargement (4.3%), RV systolic dysfunction (2.2%) and myocardial fibrosis (12.0%) were identified. On average, the LV and RV ejection fractions of acromegaly patients were higher than the healthy reference values. Male patients had thicker LV myocardia, wider ventricular diameters and more dilated pulmonary artery roots than female patients. After surgery, LV myocardial hypertrophy was reversed, the left atrium was remodeled, and ventricular systolic dysfunction recovered to normal. Cardiac alterations were detected early in the 3(rd) postoperative month and persisted until the 12(th) month. The interventricular septum was initially thickened in the 3(rd) postoperative month and then recovered at the 12th month. Notable postoperative cardiac reversibility was observed in male patients but did not occur in all female patients. Patients achieving endocrine remission with normalized hormone levels had thinner LV myocardia than patients without normalized hormone levels. CONCLUSION: Our findings demonstrated that some of the cardiac involvement in acromegaly patients is reversible after surgical treatment which lowers hormone levels. Endocrine remission and gender significantly impacted postoperative cardiac reversibility.
format Online
Article
Text
id pubmed-7609918
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76099182020-11-13 Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance Guo, Xiaopeng Cao, Yihan Cao, Jian Li, Xiao Liu, Peijun Wang, Zihao Gao, Lu Bao, Xinjie Xing, Bing Wang, Yining Front Endocrinol (Lausanne) Endocrinology PURPOSE: Cardiac comorbidity is one of the leading causes of death among acromegaly patients. We aimed to investigate the reversibility of acromegalic cardiac involvement after surgical treatment using the gold standard method, cardiovascular magnetic resonance, and to explore the effects of endocrine remission and gender on reversibility. METHODS: In this single-center, prospective cohort study, fifty untreated acromegaly patients were enrolled. Comprehensive cardiac assessments were performed using a 3.0 T magnetic resonance scanner before and 3 and 12 months after transsphenoidal adenomectomy. RESULTS: Preoperatively, left ventricular (LV) enlargement (13.0%), LV systolic dysfunction (6.5%), right ventricular (RV) enlargement (4.3%), RV systolic dysfunction (2.2%) and myocardial fibrosis (12.0%) were identified. On average, the LV and RV ejection fractions of acromegaly patients were higher than the healthy reference values. Male patients had thicker LV myocardia, wider ventricular diameters and more dilated pulmonary artery roots than female patients. After surgery, LV myocardial hypertrophy was reversed, the left atrium was remodeled, and ventricular systolic dysfunction recovered to normal. Cardiac alterations were detected early in the 3(rd) postoperative month and persisted until the 12(th) month. The interventricular septum was initially thickened in the 3(rd) postoperative month and then recovered at the 12th month. Notable postoperative cardiac reversibility was observed in male patients but did not occur in all female patients. Patients achieving endocrine remission with normalized hormone levels had thinner LV myocardia than patients without normalized hormone levels. CONCLUSION: Our findings demonstrated that some of the cardiac involvement in acromegaly patients is reversible after surgical treatment which lowers hormone levels. Endocrine remission and gender significantly impacted postoperative cardiac reversibility. Frontiers Media S.A. 2020-10-21 /pmc/articles/PMC7609918/ /pubmed/33193111 http://dx.doi.org/10.3389/fendo.2020.598948 Text en Copyright © 2020 Guo, Cao, Cao, Li, Liu, Wang, Gao, Bao, Xing and Wang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Guo, Xiaopeng
Cao, Yihan
Cao, Jian
Li, Xiao
Liu, Peijun
Wang, Zihao
Gao, Lu
Bao, Xinjie
Xing, Bing
Wang, Yining
Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
title Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
title_full Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
title_fullStr Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
title_full_unstemmed Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
title_short Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
title_sort reversibility of cardiac involvement in acromegaly patients after surgery: 12-month follow-up using cardiovascular magnetic resonance
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609918/
https://www.ncbi.nlm.nih.gov/pubmed/33193111
http://dx.doi.org/10.3389/fendo.2020.598948
work_keys_str_mv AT guoxiaopeng reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT caoyihan reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT caojian reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT lixiao reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT liupeijun reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT wangzihao reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT gaolu reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT baoxinjie reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT xingbing reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance
AT wangyining reversibilityofcardiacinvolvementinacromegalypatientsaftersurgery12monthfollowupusingcardiovascularmagneticresonance